A Study Evaluating the Safety and Tolerability of QRL-201 in ALS
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Manoj Malhotra, MD
QurAlis Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Universitaire Ziekenhuizen Leuven (uz Leuven)
Leuven, Belgium
- University of Calgary
Calgary, Alberta, Canada
- University of Alberta
Edmonton, Alberta, Canada
- Sunnybrook Health Science Centre
Toronto, Ontario, Canada
- Chum - Hopital Notre-Dame
Montreal, Quebec, Canada
- Montreal Neurological Institute-Hospital
Montreal, Quebec, Canada
- Deutsches Zentrum Für Neurodegenerative Erkrankungen E. V. (dzne)
Bonn, North Rhine-Westphalia, Germany
- Charité Research Organisation
Berlin, Germany
- University Hospital Schleswig-Holstein (uksh) Campus Lübeck, Department for Neurology/ Precision Neurology
Lübeck, Germany
- Universitätsklinikum Ulm
Ulm, Germany
- St James'S Hospital
Dublin, Ireland
- Universitair Medisch Centrum Utrecht
Utrecht, Netherlands
- the University of Sheffield, Royal Hallamshire Hospital
Sheffield, United Kingdom, United Kingdom
- Kings College Hospital Nhs Foundation Trust
London, United Kingdom
- National Hospital for Neurology and Neurosurgery
London, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Dec 2022
- Primary completion
- 29 May 2026
- Completion
- 30 Nov 2027
- Last update posted
- 15 May 2026
- Registered enrollment
- 69
- Registry id
- NCT05633459
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.